Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
3qcj | NX4 | Receptor-type tyrosine-protein phosphatase gamma | 3.1.3.48 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
3qcj | NX4 | Receptor-type tyrosine-protein phosphatase gamma | 3.1.3.48 | 1.000 | |
3qck | NX5 | Receptor-type tyrosine-protein phosphatase gamma | 3.1.3.48 | 0.635 | |
3qcl | NXV | Receptor-type tyrosine-protein phosphatase gamma | 3.1.3.48 | 0.601 | |
3qch | NX2 | Receptor-type tyrosine-protein phosphatase gamma | 3.1.3.48 | 0.560 | |
3qci | NX3 | Receptor-type tyrosine-protein phosphatase gamma | 3.1.3.48 | 0.531 | |
3oag | LPQ | Renin | 3.4.23.15 | 0.455 | |
3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.455 | |
3eon | 341 | Glutaryl-CoA dehydrogenase | / | 0.454 | |
2qo4 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.450 | |
3g70 | A5T | Renin | 3.4.23.15 | 0.447 | |
1o8c | NDP | Probable acrylyl-CoA reductase AcuI | 1.3.1.84 | 0.445 | |
4a95 | 9MT | Glycylpeptide N-tetradecanoyltransferase | / | 0.445 | |
3k1w | BFX | Renin | 3.4.23.15 | 0.443 | |
4bb6 | HD1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.443 | |
4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.443 | |
1xdd | AAY | Integrin alpha-L | / | 0.442 | |
2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.442 | |
4fw0 | 5KJ | Nitric oxide synthase, brain | 1.14.13.39 | 0.442 | |
2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.441 | |
3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.441 |